Skip to main content
SpringerLink
Log in

Rationale for Non-surgical Interventional Treatment of Hepatocellular Carcinoma

  • Chapter
Liver Malignancies

Part of the book series: Medical Radiology ((Med Radiol Diagn Imaging))

Abstract

Hepatocellular carcinoma (HCC) is still seen as a neoplasm with a very grim prognosis. This concept was established decades ago, when the diagnosis was almost always achieved at an advanced stage or even after death. However, the availability of ultrasound (US) and its wide use in the conventional clinical setting for the evaluation of patients with suspicion of liver disease has prompted a radical change in the timing of diagnosis. Patients with HCC may be now diagnosed at an early asymptomatic stage (Okuda 1986) when potentially effective therapies can be indicated and this has raised a marked interest in defining the criteria and staging systems that should be used to properly manage HCC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Araya V, Rakela J, Wright T (1997) Hepatitis C after orthotopic liver transplantation. Gastroenterology 112:575–582

    Article  PubMed  CAS  Google Scholar 

  • Arroyo V, Ginès P, Rimola A, et al (1986) Renal function abnormalities, prostaglandins, and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites. Am J Med 81:104–122

    Article  PubMed  CAS  Google Scholar 

  • Attali P, Prod’Homme S, Pelletier G, et al (1987) Prognostic factors in patients with hepatocellular carcinoma. Attemps for selection of patients with prolonged survival. Cancer 45:2108–2111

    Article  Google Scholar 

  • Barbara L, Benzi G, Gaiani S, et al (1992) Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumour growth rate and patient survival. Hepatology 16:132–137

    Article  PubMed  CAS  Google Scholar 

  • Bataller R, Sort P, Ginés P, et al (1998) Hepatorenal syndrome: definition, pathophysiology, clinical features and management. Kidney Int 53:547–553

    Google Scholar 

  • Bismuth H, Chiche L, Adam R, et al (1993) Liver resection versus transplantation for hepatocellular carcinoma in cirrhosis. Ann Surg 218:145–151

    Article  PubMed  CAS  Google Scholar 

  • Borzio M, Bruno S, Roncalli M, et al (1995) Liver cell dysplasia is a major risk factor for hepatocellular carcinoma: a prospective study. Gastroenterology 108:812–817

    Article  PubMed  CAS  Google Scholar 

  • Bruix J (1993) Diagnostico temprano del carcinoma hepatocellular: implicaciones clinicas. Med Clin (Barc) 100:228–234

    CAS  Google Scholar 

  • Bruix J (1997) Treatment of hepatocellular carcinoma. Hepatology 25:259–262

    Article  PubMed  CAS  Google Scholar 

  • Bruix J, Barrera JM, Calvet X, et al (1989) Prevalence of antibodies to hepatitis C virus in spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1004–1006

    Google Scholar 

  • Bruix J, Castells A, Bru C (1991) Características clínicas y pronóstiсo del carcinoma hepatocelular. ίExisten diferencias geográficas? Gastroenterol Hepatol 14:520–524

    Google Scholar 

  • Bruix J, Castells A, Bru C (1992) Diagnosis and treatment of hepatocellular carcinoma. A western perspective. Cancer J 5:17–22

    Google Scholar 

  • Bruix J, Castells A, Bosch J, et al (1996) Surgical resection of hepatocellular carcinoma in cirrhotic patients. Prognostic value of preoperative portal pressure. Gastroenterology 111:1018–1022

    Article  PubMed  CAS  Google Scholar 

  • Bruix J, Llovet JM, Castells A, et al (1998) Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma. Results of a randomizated controlled trial in a single institution. Hepatology 27:1578–1583

    Article  PubMed  CAS  Google Scholar 

  • Calvet X, Bruix J, Ginés P, et al (1990) Prognostic factors of hepatocellular carcinoma in the West: a multivariate analysis in 206 patients. Hepatology 12:753–760

    Article  PubMed  CAS  Google Scholar 

  • Castells A, Bruix J, Bru C, et at (1993) Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology 18:1121–1126

    PubMed  CAS  Google Scholar 

  • Castells A, Bruix J, Bru C, et al (1995) Treatment of hepatocellular carcinoma with tamoxifen: a double-blind placebo-controlled trial in 120 patients. Gastroenterology 109:917–922

    Article  PubMed  CAS  Google Scholar 

  • Collier J, Sherman M, (1998) Screening for hepatocellular carcinoma. Hepatology 27:273–278

    Article  PubMed  CAS  Google Scholar 

  • Colombo M, De Franchis R, Del Ninno E, et al (1991) Hepatocellular carcinoma in Italian patients with cirrhosis. N Eng J Med 325:675–680

    Article  CAS  Google Scholar 

  • Cottone M, Virdone R, Fusco G, et al (1989) Asymptomatic hepatocellular carcinoma in Child’s A cirrhosis. A cornparison of natural history and treatment. Gastroenterology 96:1566–1571

    PubMed  CAS  Google Scholar 

  • Cottone M, Turri M, Caltagirone M, et al (1994) Screening for hepatocellular carcinoma in patients with Child’s A cirrhosis: an 8-year prospective study by ultrasound and alpha-fetoprotein. J Hepatol 21:1029–1034

    Article  PubMed  CAS  Google Scholar 

  • D’Amico G, Pagliaro L, Bosch J (1995) The treatment of portal hypertension: a meta-analytic review. Hepatology 22:332–354

    PubMed  Google Scholar 

  • Ebara M, Ohto M, Shinagawa T, et al (1986) Natural history of hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients. Gastroenterology 90:289–298

    PubMed  CAS  Google Scholar 

  • Elizalde JI, Castells A, Planas R, et al (1996) Prevalencia del carcinoma hepatocelular en pacientes cirróticos portadores de una derivación portosistémica. Análisis de cohortes. Gastroenterol Hepatol 19:189–193

    PubMed  CAS  Google Scholar 

  • Figueras J, Jaurrieta E, Valls C, et al (1997) Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology 25:1485–1489

    Article  PubMed  CAS  Google Scholar 

  • Franco D, Capussotti L, Smadja C, et al (1990) Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis. Gastroenterology 98:733–738

    PubMed  CAS  Google Scholar 

  • Fuster J, Garcia-Valdecasas JC, Grande L, et al (1996) Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series. Ann Surg 223:297–302

    Article  PubMed  CAS  Google Scholar 

  • Gane E, Naoumov N, Qian K, et al (1996) A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 110:167–177

    Article  PubMed  CAS  Google Scholar 

  • Ganne-Carrie N, Castaign C, Chapel F, et a1 (1996) Preditive score for the development of hepatocelular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis. Hepatology 23:1112–1118

    Article  PubMed  CAS  Google Scholar 

  • Group d’Etude et de Traitement de Carcinome Hepatocellulaire (1995) A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 332:1256–1261

    Article  Google Scholar 

  • Honda N, Guo Q, Uchida H, et al (1994) Percutaneous hot saline injection therapy for hepatic tumors: an alternative to percutaneous ethanol injection therapy. Radiology 190:53–57

    PubMed  CAS  Google Scholar 

  • Ikeda K, Saitoh S, Koida I, et al (1993) A multivariate analysis of risk factors for hepatocellular carcinoma: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 18:47–53

    Article  PubMed  CAS  Google Scholar 

  • International Union Against Cancer (UICC) (1997) TNM classification of malignant tumours, 5th edn. Sobin LH, Wittekind Ch (eds). New York, Wiley- Liss, pp 74–77

    Google Scholar 

  • Ishii H, Okada S, Nose H, et al (1996) Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection. Cancer 77:1792–1796

    Article  PubMed  CAS  Google Scholar 

  • Iwatsuki S, Gordon RD, Shaw BW, et al (1985) Role of liver transplantation in cancer therapy. Ann surg 202:401–407

    Article  PubMed  CAS  Google Scholar 

  • Izumi R, Shimizu K, Ii T, et al (1994) Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 106:720–727

    PubMed  CAS  Google Scholar 

  • Johnson PJ, Williams R (1987) Cirrhosis and the aetiology of hepatocellular carcinoma. J Hepatol 4:140–147

    Article  PubMed  CAS  Google Scholar 

  • Kalayci C, Johnson PJ, Raby N et al (1990) Intrarterial adriamycin and lipiodol for inoperable hepatocellular carcinoma: a comparison with intravenous adriamycin. J Hepatol 11:349–353

    Article  CAS  Google Scholar 

  • Kanematsu T, Furuta T, Takenaka K, et a1 (1989) A 5-year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology 10:98–102

    Article  PubMed  CAS  Google Scholar 

  • Lencioni R, Paolicchi A, Moretti M, et al (1998) Combined transcatheter arterial embolization and percutaneous ethanol injection for the treatment of large hepatocellular carcinoma: local therapeutic effect and long-term survival rate. Eur Radiol 8:439–444

    Article  PubMed  CAS  Google Scholar 

  • Liaw YF, Tai DI, Chu C, et al (1986) Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. Gastroenterology 90:263–267

    PubMed  CAS  Google Scholar 

  • Livraghi T, Bolondi L, Buscarini L, et al (1995) No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. J Hepatol 22:522–526

    Article  PubMed  CAS  Google Scholar 

  • Livraghi T, Benedini V, Lazzaroni S, et al (1998) Long term results of single session percutaneous ethanol injection in patients with large hepatocellular carcinoma. Cancer 83:48–57

    Article  PubMed  CAS  Google Scholar 

  • Llovet JM, Bruix J, Fuster J, et al (1998) Liver transplantation for treatment of small hepatocellular carcinoma: the TNM classification does not have prognostic power. Hepatology 27:1572–1577

    Article  PubMed  CAS  Google Scholar 

  • Llovet JM, Bustamante J, Castells A, et al (1999) Natural history of untreated non-surgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 29:62–67

    Article  PubMed  CAS  Google Scholar 

  • Makuuchi M, (1995) Surgical treatment for hepatocellular carcinoma. In: Arroyo V, Bosch J, Rodés J (eds) Treatments in Hepatology. Masson, Barcelona, pp 341–352

    Google Scholar 

  • Marsh W, Dvorchik I, Subotin M, et al (1997) The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology 26:444–450

    Article  PubMed  CAS  Google Scholar 

  • Mazzaferro V, Regalia E, Doci R, et al (1996) Liver transplantation for treatment of small hepatocellular carcinc mas in patients with cirrhosis. N Engl J Med 334:693–699

    Article  PubMed  CAS  Google Scholar 

  • McPeake JR, O’Grady JG, Zaman S, et al (1993) Liver transplantation for primary hepatocellular carcinoma: tumor size and number determine outcome. J Hepatol 18:226–234

    Article  PubMed  CAS  Google Scholar 

  • Mehta R (1995) The potential for the use of cell proliferation and oncogene expression as intermediate markers during liver carcinogenesis. Cancer Lett 93:85–102

    Article  PubMed  CAS  Google Scholar 

  • Muto Y, Moriwaki H, Ninomiya M, et al (1996) Prevention of secondary primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. N Eng J Med 334:1561–1567

    Article  CAS  Google Scholar 

  • Nagasue N, Galizia G, Kohno H, et al (1989) Adverse effects of preoperative hepatic artery chemoembolization for resectable hepatocellular carcinoma: a retrospective comparison of 138 liver resections. Surgery 106:81–86

    PubMed  CAS  Google Scholar 

  • Nakashima T, Kojiro M, (1987) Hepatocellular Carcinoma. Springer Verlag, Tokyo

    Book  Google Scholar 

  • Navasa M, Forns X, Sánchez V, et al (1996) Quality oł life, major medical complications and hospital service utilization in patients with primary biliary cirrhosis after liver transplantation. J Hepatol 25:129–134

    Article  PubMed  CAS  Google Scholar 

  • Navasa M, Rimola A, Rodés J (1997) Bacterial infectio:Is in liver disease. Sem Liv Dis 17:323–333

    Article  CAS  Google Scholar 

  • Nerenstone SR, Ihde DC, Friedman MA (1986) Clinical trials in primary hepatocellular carcinoma: current status and future directions. Cancer Treat Rev 15:1–31

    Article  Google Scholar 

  • O’Grady JG, Poison RJ, Rolles K, et al (1988) Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg 207:373–379

    Article  PubMed  Google Scholar 

  • Ohnishi K, Yoshioka H, Ito S, et al (1998) Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology 27:67–72

    Article  PubMed  CAS  Google Scholar 

  • Okada S, Okazaki N, Nose H, et al (1992) Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Hepatology 16:112–117

    Article  PubMed  CAS  Google Scholar 

  • Okada S, Shimada K, Yamamoto J, et al (1994) Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology 106:1618–1624

    PubMed  CAS  Google Scholar 

  • Okamoto E, Kyo A, Yamanaka N, et al (1984) Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function. Surgery 95:586–592

    PubMed  CAS  Google Scholar 

  • Okazaki N, Yoshino M, Yoshida T. et al (1988) Evaluation of the prognosis for small hepatocellular carcinoma based on tumor volume doubling time. Cancer 83:2207–2210

    Google Scholar 

  • Okuda K, (1986) Early recognition of hepatocellular carcinoma. Hepatology 6:729–738

    Article  PubMed  CAS  Google Scholar 

  • Okuda K, (1992) Hepatocellular carcinoma: recent progress. Hepatology 15:948–963

    Article  PubMed  CAS  Google Scholar 

  • Okuda K, Ohtsuki T, Obata H, et al (1985) Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Cancer 56:918–928

    Article  PubMed  CAS  Google Scholar 

  • Pereira SP, Williams R (1998) Limits to liver transplantation in the UK. GUT 42:883–885

    Article  PubMed  CAS  Google Scholar 

  • Pichlmayr R, Weimann A, Oldhafer KJ, et al (1995) Role of liver transplantation in the treatment of unresectable liver cancer. World J Surg 19:807–813

    Article  PubMed  CAS  Google Scholar 

  • Poynard T, Aubert A, Lazizi Y, et al (1991) Independent risk factors for hepatocellular carcinoma in french drinkers. Hepatology 13:896–90

    Article  PubMed  CAS  Google Scholar 

  • Pugh RNH, Murray-Lyon IM, Dawson JL, et al (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646–664

    Article  PubMed  CAS  Google Scholar 

  • Raoul JL, Guyader D, Bretagne JF, et al (1997) Prospective randomized controlled trial of chemoembolization versus intra-arterial injection of 131-I-labeled iodized oil in the treament of hepatocellular carcinoma. Hepatology 26:1156–1161

    PubMed  CAS  Google Scholar 

  • Ringe B, Wittekind C, Bechstein WO, et al (1989) The role of liver transplantation in hepatobiliary malignancy. Ann Surg 209:88–98

    Article  PubMed  CAS  Google Scholar 

  • Sarasin FP, Giostra E, Hadengue A (1996) Cost-effectiveness of screening for detection of small hepatocelular carcinoma in Western patients with Child-Pugh class A cirrhosis. Am J Med 17:422–434

    Article  Google Scholar 

  • Sato Y, Nakata K, Kato Y, et al (1993) Early recognition of hepatocellular carcinoma based on altered profiles of alphafetoprotein. N Eng J Med 328:1802–1806

    Article  CAS  Google Scholar 

  • Sherman M, Peltekian KM, Lee C (1995) Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a north american urban population. Hepatology 22:432–438

    PubMed  CAS  Google Scholar 

  • Sheu JC, Sung JL, Chen DS, et al (1985) Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology 89:259–266

    PubMed  CAS  Google Scholar 

  • Shibata M, Morizane T, Uchida T, et al (1998) Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis C virus infection. Lancet 351:1773–1777

    Article  PubMed  CAS  Google Scholar 

  • Shirabe K, Kanematsu T, Matsumata T, et al (1991) Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy:univariate and multivariate analysis. Hepatology 14:802–805

    Article  PubMed  CAS  Google Scholar 

  • Simonetti RG, Liberati A, Angiolini C, et al (1997) Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials. Ann Oncol 8:117–136

    Article  PubMed  CAS  Google Scholar 

  • Sorensen JB, Klee M, Palshof T. et a1 (1993) Performance status assessment in cancer patients. An inter-observer variability study. Br J Cancer 67:773–775

    Article  PubMed  CAS  Google Scholar 

  • Stone MJ, Klintmalm GB, Polter D, et a1 (1993) Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients. Gastroenterology 104:196–202

    PubMed  CAS  Google Scholar 

  • Stuart KE, Anand AJ, Jenkins RL (1996) Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer 77:2217–22

    Article  PubMed  CAS  Google Scholar 

  • Sudan D, Sudan R, Schafer D, et al (1998) Without victory there is no survival: transarterial lipiodol chemoembolization and hepatocellular carcinoma. Hepatology 28:270–271

    Article  PubMed  CAS  Google Scholar 

  • Takano S, Yokosuka O, Imazeki K, et al (1995) Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology 21:650–655

    Article  PubMed  CAS  Google Scholar 

  • Taketa K, (1990) Alpha-fetoprotein: reevaluation in hepatology. Hepatology 12:1420–1432

    Article  PubMed  CAS  Google Scholar 

  • Tang ZY, Yang BH (1985) Early detection of subclinical hepatocellular carcinoma. In: Tang ZY (ed) subclinical hepatocellular carcinoma.Springer Verlag, Berlin, pp 1221

    Google Scholar 

  • Tang ZY, Bing-Hui Y (1989) Further evaluation of alpha-fetoprotein as tumor marker for hepatocellular carcinoma -with special reference to subclinical cancer. In: Tang ZY, Wu MC, Xia SS (eds) Primary Liver Cancer. China Academic Publishers, Beijing and Springer Verlag, Berlin, pp 239–246

    Google Scholar 

  • Trinchet JC, Beaugrand M, (1997) Treatment of hepatocellular carcinoma in patients with cirrhosis. J Hepatol 27:756–765

    Article  PubMed  CAS  Google Scholar 

  • Tsukuma H, Hiyama I, Tanaka S, et al (1993) Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Eng J Med 328:797–801

    Article  Google Scholar 

  • Vilana R, Bruix J, Brú C, et a1 (1992) Tumor sizes determines the efficacy of percutaneous ethanol injection for treatment of small hepatocellular carcinoma. Hepatology 16:353–357

    Article  PubMed  CAS  Google Scholar 

  • Weitz IC, Liebman HA, (1993) Des-gamma-carboxy (abnormal) prothrombin and hepatocellular carcinoma: a critical review. Hepatology 18:990–997

    Article  PubMed  CAS  Google Scholar 

  • Yokoyama I, Todo S, Iwatsuki S, et a1 (1990) Liver transplantation in the treatment of primary liver cancer. Hepatogastroenterology 37:188–193

    PubMed  CAS  Google Scholar 

  • Yokoyama I, Sheahan DG, Carr B, et al (1991) Clinicopathologic factors affecting patient survival and tumor recurrence after orthotopic liver transplantation for hepatocellular carcinoma. Transplant Proc 23:2194–2196

    PubMed  CAS  Google Scholar 

  • Zetterman RK, McCashland TM (1995) Long-term follow-up of the orthotopic liver transplantation patient. Semin Liv Dis 15:173–180

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Liver Unit, Hospital Clinic, University of Barcelona, Villarroel 170, E-08036, Barcelona, Spain

    J. Bruix MD

  2. Department of Radiology, Hospital Clinic, University of Barcelona, Villarroel 170, E-08036, Barcelona, Spain

    C. Bru MD

Authors
  1. J. Bruix MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Bru MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Diagnostic and Interventional Radiology, Department of Oncology, University of Pisa, Via Roma 67, I-56125, Pisa, Italy

    C. Bartolozzi MD (Professor and Chairman) & R. Lencioni MD (Professor and Chairman) & 

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Bruix, J., Bru, C. (1999). Rationale for Non-surgical Interventional Treatment of Hepatocellular Carcinoma. In: Bartolozzi, C., Lencioni, R. (eds) Liver Malignancies. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-58641-5_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-58641-5_16

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-63679-0

  • Online ISBN: 978-3-642-58641-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation